NCT00534820已完成不适用
Cytogenetic Analysis of Bone Marrow Specimen Prior to High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients With Non-Hodgkin's Lymphoma or Hodgkin's Disease
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 450
- 试验地点
- 2
- 主要终点
- Efficacy
研究概览
简要总结
Cytogenetic Analysis of Bone Marrow Specimen Prior to High Dose Chemotherapy and Autologous Stem Cell Transplantation in Patients with Non-Hodgkin's Lymphoma or Hodgkin's Disease
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Basic Science
- 盲法
- None
入排标准
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients with Non-Hodgkin's Lymphoma or Hodgkin's Disease
排除标准
- 未提供
结局指标
主要结局
Efficacy
时间窗: 6 years
次要结局
未报告次要终点
研究者
Dr. Naeem A. Chaudhri
Principal Investigator
King Faisal Specialist Hospital & Research Center
研究点 (2)
Loading locations...
相似试验
已完成
不适用
Biomarkers in Bone Marrow Samples From Patients With Acute Myeloid LeukemiaLeukemiaNCT01251159ECOG-ACRIN Cancer Research Group30
已完成
不适用
Use of FDG PET as Predictor of Residual Disease and Subsequent Relapse in Patients With NHL and HD Undergoing HDC and ASCTLymphoma, Non-HodgkinHodgkin DiseaseNCT00534989King Faisal Specialist Hospital & Research Center10
已完成
不适用
S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic CancersMyelodysplastic SyndromesMyelodysplastic/Myeloproliferative NeoplasmsLeukemiaNCT00996047SWOG Cancer Research Network3,341
Unknown
不适用
Biomarkers in Patients at Risk of Developing Myelodysplastic Syndrome or Other Disorders and in Healthy ParticipantsLeukemiaMyelodysplastic SyndromesNCT00899327Oxford University Hospitals NHS Trust200
已完成
不适用
Biomarkers to Classify Young Patients With Acute Lymphoblastic Leukemia (ALL) and Remission Induction Therapy in Young Patients With B-Precursor ALLLeukemiaNCT01225874Children's Oncology Group3,762